台股 » 個股 » 生展 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生展

(8279)
  • 股價
    158.0
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    17
  • 產業
    上櫃 生技醫療類股
  • 68人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
生展 (8279)籌碼相關-元富-新興 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元富-新興 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/03/1200.003157.50157.50-310-29.32%
2024/03/073151.0000.00151.003932.67%
2023/10/232161.0000.00161.0021019.90%
2023/10/172161.002165.00165.00090.00%
2023/10/1300.002168.00168.00-210-19.17%
2023/10/031166.0000.00166.001118.39%
2023/10/0200.001167.50167.00-111-8.35%
2023/09/281166.0000.00166.001128.08%
2023/09/2500.001168.00168.00-113-7.56%
2023/07/035169.1000.00168.505529.59%
2023/06/156172.4200.00172.5065211.33%
2023/06/144172.0000.00173.004537.50%
2023/04/2600.005180.00183.50-552-9.61%
2023/04/255177.005188.00177.000510.00%
2023/04/2400.004181.00181.00-449-8.09%
2023/04/211175.5000.00180.001492.04%
2023/04/1900.002183.50183.50-249-4.07%
2023/04/1300.005177.00177.50-544-11.25%
2023/03/226165.5000.00165.0065810.23%
2023/03/219164.2800.00164.5095915.13%
2023/03/1000.003168.50171.00-365-4.59%
2023/03/093175.0000.00173.003654.58%
2023/03/0700.001181.00177.50-160-1.64%
2023/03/0200.006170.50173.00-658-10.29%
2023/03/0100.006168.67168.50-657-10.46%
2023/02/2400.003168.00166.00-357-5.21%
2023/02/084160.0000.00160.004666.01%
2023/02/016154.8300.00157.006668.99%
2023/01/305155.0000.00156.005677.46%
2022/12/221155.008157.94158.00-762-11.23%
2022/12/2100.003157.50157.00-361-4.86%
2022/12/145156.7000.00155.505608.23%
2022/12/135160.0000.00159.505618.15%
2022/12/1200.005162.10161.00-560-8.29%
2022/12/0900.002160.00160.00-259-3.36%
2022/12/021145.0000.00148.501611.64%
2022/11/256137.6700.00138.006688.73%
2022/08/2200.002174.25170.00-281-2.44%
2022/08/1100.001147.00150.00-159-1.67%
2022/08/1000.0014143.32146.00-1456-24.88%
2022/08/055132.0000.00132.0054810.37%
2022/07/251130.5000.00130.501462.15%
2022/07/221131.0000.00131.001462.13%
2022/07/063115.5000.00118.003486.19%
2022/07/047114.5700.00115.5074814.39%
2022/01/2100.001126.00126.00-147-2.09%
2022/01/201124.501126.50128.000450.00%
2022/01/191117.0000.00117.501392.53%
2021/11/1700.001103.50104.50-121-4.63%
2021/11/1500.001103.00104.00-121-4.70%
2021/11/0100.00198.3097.90-125-3.89%
2021/08/12191.9000.0092.501412.38%
2021/08/03199.5000.0099.701382.58%
2021/07/131103.5000.00102.501382.57%
2021/06/1100.001106.50106.00-138-2.57%
2021/06/1000.001109.50108.00-137-2.65%
2021/06/071100.5000.00101.001362.77%
2021/05/051107.5000.00108.001432.29%
2021/03/1200.001112.00113.50-152-1.92%
2021/03/101111.0000.00109.501501.97%
2021/03/0200.002111.75111.00-251-3.87%
2021/02/231109.5000.00109.501511.96%
2021/02/171104.5000.00104.501501.97%
2020/09/1100.005112.00112.50-5131-3.80%
2020/08/205132.0000.00125.5051214.12%
2018/07/0400.001140.00138.00-1211-0.47%
2018/06/0400.001156.50156.50-1297-0.34%
2018/06/011153.0000.00152.0012950.34%
2018/04/242167.002167.00161.5003740.00%
2018/01/0300.001154.50153.00-1269-0.37%
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
〈聯合再生展望〉洪傳獻:TOPCon技術明年成主流 獲利表現佳Anue鉅亨-2023/10/16
生展 相關文章